MAGELLAN LONGEVITY
HomeTopical Pain Relief › Capzasin-HP Capsaicin 0.1% Pain Relief Cream

Capzasin-HP Capsaicin 0.1% Pain Relief Cream

Written and medically reviewed by , physiatrist · Last reviewed · How we grade
In one paragraph

Capzasin-HP Capsaicin 0.1% Pain Relief Cream, graded Moderate-evidence on Magellan — a 2024 meta-analysis of 8 trials found a significant advantage over placebo while rating the certainty of the evidence low to very low. Network analyses place capsaicin behind topical NSAIDs for osteoarthritis, and reviewers suggest it mainly as a short-term option for people who cannot tolerate NSAIDs.

Source: Cochrane Database Syst Rev 2017, PMID 28085183 ↗ · Topical Pain Relief · How Magellan grades evidence · Study write-up · evidence confidence: high

Topical Pain Relief17 PubMed citations
$12.00 typical listed price — check the live price on Amazon
View Capzasin-HP Capsaicin 0.1% Pain Relief Cream on Amazon ↗   Open in the Magellan store →

What it is

Capsaicin is the pungent alkaloid responsible for the heat of chili peppers (Capsicum species). Applied to the skin, it binds the transient receptor potential vanilloid 1 (TRPV1) receptor on sensory nerve fibers, triggering release and then depletion of the pain neurotransmitter substance P and, with repeated use, a reversible 'defunctionalization' or desensitization of pain-signaling nociceptors. Low-concentration topical capsaicin creams (commonly 0.025% to 0.1%) are sold over the counter for temporary relief of minor musculoskeletal and arthritis pain, while a high-concentration 8% patch is applied under medical supervision for neuropathic pain.

Its role in longevity

Randomized trials and meta-analyses show that topical capsaicin produces modest reductions in pain from hand and knee osteoarthritis — a 2024 meta-analysis of 8 trials found a significant advantage over placebo while rating the certainty of the evidence low to very low — and it offers benefit in neuropathic conditions such as postherpetic neuralgia, where the strongest data are for the high-concentration 8% prescription patch. Network analyses place capsaicin behind topical NSAIDs for osteoarthritis, and reviewers suggest it mainly as a short-term option for people who cannot tolerate NSAIDs. Onset is slow (often 1 to 4 weeks of repeated daily application), and burning or stinging at the application site is very common — in the 2024 analysis about one extra user in three experienced it, for a number-needed-to-harm of 3 — though capsaicin avoids the gastrointestinal and cardiovascular risks of oral NSAIDs. Blinding is difficult because of that characteristic burning, so several reviews rate its efficacy as modest or uncertain. This evidence describes the capsaicin compound and its TRPV1 mechanism generally, not this specific commercial product.

The research

Peer-reviewed studies on the active compound — citations link to PubMed.

“High-concentration topical capsaicin used to treat postherpetic neuralgia, HIV-neuropathy, and painful diabetic neuropathy generated more participants with moderate or substantial levels of pain relief than control.”
Cochrane Database Syst Rev 2017 · PMID 28085183
“Mean pain reduction was 1.2 on ibuprofen and 1.6 on capsaicin... 59% of people displayed a greater response to one treatment over the other.”
Rheumatology (Oxford) 2021 · PMID 33197270
“Capsaicin treatment efficacy (vs. placebo) for change in VAS pain score was moderate, at 0.44 (95% CI 0.25-0.62) over 4 weeks of treatment.”
Prog Drug Res 2014 · PMID 24941673
“The relative benefit from topical capsaicin 0.025% or plaster compared with placebo was 1.5 (1.1 to 2.0) and the number needed to treat was 8.1 (4.6 to 34).”
BMJ 2004 · PMID 15033881
“Current evidence indicates that topical NSAIDs and capsaicin in licensed doses may be equally effective for pain relief in OA.”
Osteoarthritis Cartilage 2018 · PMID 30172837
“High-concentration topical capsaicin… generated more participants with moderate or substantial levels of pain relief than control… usually with additional improvements in sleep, fatigue, depression, and quality of life.”
Cochrane Database Syst Rev 2017 · PMID 28085183

Research describes the active mechanism and is not a claim about this specific product.

Educational information, not medical advice. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if pregnant, nursing, or taking medication.

More in Topical Pain Relief

Voltaren Arthritis Pain Gel (Diclofenac 1%)

Randomized trials and meta-analyses, including Cochrane reviews, indicate that topical…

Aspercreme 4% Lidocaine Pain Relief Cream

The best-supported use of topical lidocaine is localized neuropathic pain, especially…

Biofreeze Menthol Pain Relief Gel

Menthol is used for the temporary relief of minor muscle and joint pain, including…

Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol)

Randomized trials of methyl-salicylate/menthol patches and menthol-based topical…

See all Topical Pain Relief →

FAQ

Does Capzasin-HP Capsaicin 0.1% Pain Relief Cream have scientific evidence?

Yes — its active compound is linked to 17 peer-reviewed studies, summarized and cited above.

Where can I buy Capzasin-HP Capsaicin 0.1% Pain Relief Cream?

You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.

Is Capzasin-HP Capsaicin 0.1% Pain Relief Cream safe?

Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.